Cardiovascular complications in chronic active Epstein-Barr virus infection: a narrative review

Jing Xu1, Yunfeng Wei1, Lin Shi2

  • 1Department of Ultrasound, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.

Insights

Cardiovascular complications from chronic active Epstein-Barr virus (CAEBV) infection are rare but serious. This review summarizes patient data to improve understanding and management of these cardiac issues.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • Cardiovascular involvement in chronic active Epstein-Barr virus (CAEBV) infection is an uncommon but severe complication.
  • Existing data on managing CAEBV-associated cardiovascular damage is limited.
  • This review addresses the need for comprehensive information on CAEBV's cardiac impact.

Purpose of the Study:

  • To summarize clinical characteristics, pathological features, diagnostic approaches, and treatment strategies for CAEBV-related cardiac damage.
  • To enhance awareness of cardiovascular complications associated with CAEBV infection.
  • To provide insights for clinical management of these rare conditions.

Main Methods:

  • A narrative review was conducted.
  • Searched PubMed, Embase, Web of Science, CNKI, CQVIP, and Wanfang Data databases.
  • Collected data on CAEBV infection with cardiovascular involvement.

Main Results:

  • 32 articles reporting 57 patients with CAEBV-associated cardiovascular complications were identified.
  • Median age was 11 years, with 66.7% children and 33.3% adults.
  • Coronary artery lesions, arrhythmias, and valvular issues were common in children; heart failure and pulmonary hypertension were more prevalent in adults.

Conclusions:

  • Cardiovascular involvement in CAEBV infection poses significant diagnostic and therapeutic challenges.
  • Systematic evaluation is crucial for timely intervention and surveillance.
  • Further research is needed to understand pathogenic mechanisms and optimize treatment due to poor prognosis.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
801
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
324
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
964
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
881
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
578